CORE LABORATORIES N V Quarterly Return On Equity in % from Q1 2011 to Q1 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Core Laboratories N V quarterly/annual Return On Equity history and growth rate from Q1 2011 to Q1 2023.
  • Core Laboratories N V Return On Equity for the quarter ending March 31, 2023 was 12.7 %, a 110% increase year-over-year.
  • Core Laboratories N V annual Return On Equity for 2022 was 10.9 %, a 13.9% decline from 2021.
  • Core Laboratories N V annual Return On Equity for 2021 was 12.7 %.
  • Core Laboratories N V annual Return On Equity for 2020 was -138 %, a 355% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 12.7 +6.65 +110% Jan 1, 2023 Mar 31, 2023
Q4 2022 10.9 -1.76 -13.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 8.99 -13.8 -60.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 5.28 -23.9 -81.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 6.06 -15 -71.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 12.7 +150 Oct 1, 2021 Dec 31, 2021
Q3 2021 22.8 +126 Jul 1, 2021 Sep 30, 2021
Q2 2021 29.2 +91.6 Apr 1, 2021 Jun 30, 2021
Q1 2021 21 +50.4 Jan 1, 2021 Mar 31, 2021
Q4 2020 -138 -192 -355% Oct 1, 2020 Dec 31, 2020
Q3 2020 -103 -158 -289% Jul 1, 2020 Sep 30, 2020
Q2 2020 -62.5 -119 -211% Apr 1, 2020 Jun 30, 2020
Q1 2020 -29.4 -87.2 -151% Jan 1, 2020 Mar 31, 2020
Q4 2019 53.9 +3.56 +7.07% Oct 1, 2019 Dec 31, 2019
Q3 2019 54.7 -4.99 -8.37% Jul 1, 2019 Sep 30, 2019
Q2 2019 56.5 -3.08 -5.17% Apr 1, 2019 Jun 30, 2019
Q1 2019 57.8 -1 -1.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 50.4 -4.43 -8.09% Oct 1, 2018 Dec 31, 2018
Q3 2018 59.7 +9.51 +19% Jul 1, 2018 Sep 30, 2018
Q2 2018 59.6 +13 +27.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 58.8 +17.2 +41.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 54.8 -1.12 -2% Oct 1, 2017 Dec 31, 2017
Q3 2017 50.1 -41.7 -45.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 46.6 -248 -84.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 41.7 +825 Jan 1, 2017 Mar 31, 2017
Q4 2016 55.9 -4.45K -98.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 91.9 -426 -82.3% Jul 1, 2016 Sep 30, 2016
Q2 2016 295 -42.9 -12.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -783 -1.03K -413% Jan 1, 2016 Mar 31, 2016
Q4 2015 4.51K +4.3K +2084% Oct 1, 2015 Dec 31, 2015
Q3 2015 518 +340 +191% Jul 1, 2015 Sep 30, 2015
Q2 2015 337 +184 +120% Apr 1, 2015 Jun 30, 2015
Q1 2015 250 +110 +78.9% Jan 1, 2015 Mar 31, 2015
Q4 2014 206 +73.2 +54.9% Oct 1, 2014 Dec 31, 2014
Q3 2014 178 +53.7 +43.1% Jul 1, 2014 Sep 30, 2014
Q2 2014 153 +33.1 +27.6% Apr 1, 2014 Jun 30, 2014
Q1 2014 140 +28.7 +25.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 133 +27.1 +25.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 125 +18.5 +17.4% Jul 1, 2013 Sep 30, 2013
Q2 2013 120 +12 +11.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 111 +13.1 +13.4% Jan 1, 2013 Mar 31, 2013
Q4 2012 106 +19.7 +22.8% Oct 1, 2012 Dec 31, 2012
Q3 2012 106 +35.1 +49.3% Jul 1, 2012 Sep 30, 2012
Q2 2012 108 +46.6 +75.8% Apr 1, 2012 Jun 30, 2012
Q1 2012 97.9 +37.7 +62.8% Jan 1, 2012 Mar 31, 2012
Q4 2011 86.4 Oct 1, 2011 Dec 31, 2011
Q3 2011 71.1 Jul 1, 2011 Sep 30, 2011
Q2 2011 61.5 Apr 1, 2011 Jun 30, 2011
Q1 2011 60.1 Jan 1, 2011 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.